PLRX
Price
$12.60
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
48 days until earnings call
TNYA
Price
$2.07
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
49 days until earnings call
Ad is loading...

PLRX vs TNYA

Header iconPLRX vs TNYA Comparison
Open Charts PLRX vs TNYABanner chart's image
Pliant Therapeutics
Price$12.60
Change-$0.00 (-0.00%)
Volume$691.57K
CapitalizationN/A
Tenaya Therapeutics
Price$2.07
Change-$0.00 (-0.00%)
Volume$689.49K
CapitalizationN/A
View a ticker or compare two or three
PLRX vs TNYA Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PLRX vs. TNYA commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Hold and TNYA is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (PLRX: $12.60 vs. TNYA: $2.07)
Brand notoriety: PLRX and TNYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 160% vs. TNYA: 192%
Market capitalization -- PLRX: $766.1M vs. TNYA: $163.3M
PLRX [@Biotechnology] is valued at $766.1M. TNYA’s [@Biotechnology] market capitalization is $163.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileTNYA’s FA Score has 1 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • TNYA’s FA Score: 1 green, 4 red.
According to our system of comparison, TNYA is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 3 TA indicator(s) are bullish while TNYA’s TA Score has 4 bullish TA indicator(s).

  • PLRX’s TA Score: 3 bullish, 5 bearish.
  • TNYA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TNYA is a better buy in the short-term than PLRX.

Price Growth

PLRX (@Biotechnology) experienced а -2.93% price change this week, while TNYA (@Biotechnology) price change was -10.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

PLRX is expected to report earnings on Nov 05, 2024.

TNYA is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($766M) has a higher market cap than TNYA($163M). PLRX YTD gains are higher at: -30.425 vs. TNYA (-36.111). TNYA has higher annual earnings (EBITDA): -118.31M vs. PLRX (-181.41M). PLRX has more cash in the bank: 437M vs. TNYA (99.3M). TNYA has less debt than PLRX: TNYA (15.6M) vs PLRX (60.2M). PLRX (0) and TNYA (0) have equivalent revenues.
PLRXTNYAPLRX / TNYA
Capitalization766M163M470%
EBITDA-181.41M-118.31M153%
Gain YTD-30.425-36.11184%
P/E RatioN/AN/A-
Revenue00-
Total Cash437M99.3M440%
Total Debt60.2M15.6M386%
TECHNICAL ANALYSIS
Technical Analysis
PLRXTNYA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 24 days ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TNYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRGSX67.250.51
+0.76%
Neuberger Berman Genesis R6
GTSDX8.940.05
+0.56%
Invesco Small Cap Growth C
BRXUX13.950.03
+0.22%
MFS Blended Research Intl Eq R4
MIMFX13.20N/A
N/A
AMG Veritas China I
MAICX8.41-0.02
-0.24%
Victory Trivalent Intl Fd-Core Eq A

TNYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNYA has been loosely correlated with PRME. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TNYA jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNYA
1D Price
Change %
TNYA100%
+4.02%
PRME - TNYA
47%
Loosely correlated
+6.95%
NTLA - TNYA
46%
Loosely correlated
+4.83%
QSI - TNYA
45%
Loosely correlated
+8.05%
PLRX - TNYA
44%
Loosely correlated
+6.15%
INZY - TNYA
43%
Loosely correlated
-2.67%
More